(S)-nicotine increases expression ISO RGD:737357 6480464 Nicotine results in increased expression of IGFBP2 mRNA CTD PMID:23825647 1,2-dichloroethane increases expression ISO RGD:10771 6480464 ethylene dichloride results in increased expression of IGFBP2 mRNA CTD PMID:28189721 , PMID:28960355 1,2-dimethylhydrazine increases expression ISO RGD:10771 6480464 1, 2-Dimethylhydrazine results in increased expression of IGFBP2 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of IGFBP2 mRNA CTD PMID:25380136 17alpha-ethynylestradiol decreases expression ISO RGD:737357 6480464 Ethinyl Estradiol results in decreased expression of IGFBP2 protein CTD PMID:15817916 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of IGFBP2 mRNA CTD PMID:29097150 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of IGFBP2 mRNA CTD PMID:12655037 , PMID:16079270 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of IGFBP2 mRNA CTD PMID:17557909 17beta-estradiol multiple interactions ISO RGD:737357 6480464 [Estradiol co-treated with Progesterone] results in increased secretion of IGFBP2 protein more ... CTD PMID:15809018 more ... 17beta-estradiol increases expression ISO RGD:737357 6480464 Estradiol results in increased expression of IGFBP2 mRNA CTD PMID:25878060 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of IGFBP2 mRNA CTD PMID:26945725 17beta-estradiol decreases expression ISO RGD:737357 6480464 Estradiol results in decreased expression of IGFBP2 mRNA CTD PMID:19619570 , PMID:21185374 17beta-estradiol increases secretion ISO RGD:737357 6480464 Estradiol results in increased secretion of IGFBP2 protein CTD PMID:15809018 17beta-hydroxy-5alpha-androstan-3-one multiple interactions ISO RGD:737357 6480464 bicalutamide promotes the reaction [Dihydrotestosterone results in increased expression of IGFBP2 mRNA], Flutamide inhibits the reaction [Dihydrotestosterone results in increased expression of IGFBP2 mRNA] CTD PMID:16368782 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:737357 6480464 Dihydrotestosterone results in increased expression of IGFBP2 mRNA CTD PMID:16368782 2,2',4,4',5,5'-hexachlorobiphenyl affects expression ISO RGD:737357 6480464 2 more ... CTD PMID:20638727 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:737357 6480464 [Hydrocarbons more ... CTD PMID:31923581 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:27291303 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:20056577 , PMID:21394737 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:737357 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of IGFBP2 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of IGFBP2 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:10771 6480464 Tetrachlorodibenzodioxin results in decreased expression of IGFBP2 mRNA CTD PMID:26290441 , PMID:33956508 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10771 6480464 Tetrachlorodibenzodioxin affects the expression of IGFBP2 mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:10771 6480464 AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of IGFBP2 mRNA] CTD PMID:15034205 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:10771 6480464 Tetrachlorodibenzodioxin results in increased expression of IGFBP2 mRNA CTD PMID:15034205 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of IGFBP2 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:737357 6480464 Tetrachlorodibenzodioxin results in decreased expression of IGFBP2 mRNA CTD PMID:19619570 , PMID:20106945 2-hydroxypropanoic acid increases expression ISO RGD:737357 6480464 Lactic Acid results in increased expression of IGFBP2 mRNA CTD PMID:30851411 2-nitrotoluene increases expression EXP 6480464 2-nitrotoluene results in increased expression of IGFBP2 mRNA CTD PMID:16460773 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO RGD:10771 6480464 3 more ... CTD PMID:19467301 3,3',5-triiodo-L-thyronine increases expression EXP 6480464 Triiodothyronine results in increased expression of IGFBP2 mRNA CTD PMID:15953391 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:737357 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of IGFBP2 mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of IGFBP2 mRNA CTD PMID:25380136 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression EXP 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of IGFBP2 mRNA CTD PMID:22484513 , PMID:23052194 4-hydroxyphenyl retinamide increases expression ISO RGD:10771 6480464 Fenretinide results in increased expression of IGFBP2 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine multiple interactions ISO RGD:737357 6480464 Decitabine inhibits the reaction [Smoke results in decreased expression of IGFBP2 mRNA] CTD PMID:21095227 5-fluorouracil increases expression ISO RGD:10771 6480464 Fluorouracil results in increased expression of IGFBP2 protein CTD PMID:21296659 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression EXP 6480464 Omeprazole affects the expression of IGFBP2 mRNA CTD PMID:19483382 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of IGFBP2 mRNA CTD PMID:19483382 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of IGFBP2 mRNA CTD PMID:24780913 9-cis-retinoic acid increases expression EXP 6480464 Alitretinoin results in increased expression of IGFBP2 mRNA CTD PMID:16648578 acrylamide decreases expression ISO RGD:737357 6480464 Acrylamide results in decreased expression of IGFBP2 mRNA CTD PMID:32763439 aflatoxin B1 affects expression ISO RGD:737357 6480464 Aflatoxin B1 affects the expression of IGFBP2 protein CTD PMID:20106945 aflatoxin B1 increases methylation ISO RGD:737357 6480464 Aflatoxin B1 results in increased methylation of IGFBP2 intron CTD PMID:30157460 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of IGFBP2 mRNA CTD PMID:23052194 , PMID:25378103 aflatoxin B1 increases expression ISO RGD:737357 6480464 Aflatoxin B1 results in increased expression of IGFBP2 mRNA CTD PMID:21632981 , PMID:21641981 aflatoxin B1 decreases expression ISO RGD:10771 6480464 Aflatoxin B1 results in decreased expression of IGFBP2 mRNA CTD PMID:19770486 Aflatoxin B2 alpha increases methylation ISO RGD:737357 6480464 aflatoxin B2 results in increased methylation of IGFBP2 intron CTD PMID:30157460 all-trans-retinoic acid multiple interactions EXP 6480464 Tretinoin affects the reaction [Oxygen affects the secretion of IGFBP2 protein] CTD PMID:16055936 all-trans-retinoic acid decreases expression ISO RGD:737357 6480464 Tretinoin results in decreased expression of IGFBP2 mRNA CTD PMID:15498508 more ... amiodarone affects expression EXP 6480464 Amiodarone affects the expression of IGFBP2 mRNA CTD PMID:19483382 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of IGFBP2 mRNA CTD PMID:16483693 anthracen-2-amine increases expression EXP 6480464 2-anthramine results in increased expression of IGFBP2 mRNA CTD PMID:23038007 antimycin A decreases expression ISO RGD:737357 6480464 Antimycin A results in decreased expression of IGFBP2 mRNA CTD PMID:33512557 arsenite(3-) increases methylation ISO RGD:737357 6480464 arsenite results in increased methylation of IGFBP2 promoter CTD PMID:23974009 arsenous acid decreases expression ISO RGD:737357 6480464 Arsenic Trioxide results in decreased expression of IGFBP2 mRNA CTD PMID:15070760 , PMID:15761015 arsenous acid multiple interactions ISO RGD:737357 6480464 [Arsenic Trioxide co-treated with Curcumin] results in decreased expression of IGFBP2 protein, Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to IGFBP2 protein] CTD PMID:26598702 , PMID:27430728 atrazine increases expression ISO RGD:737357 6480464 Atrazine results in increased expression of IGFBP2 mRNA CTD PMID:22378314 azoxystrobin decreases expression ISO RGD:737357 6480464 azoxystrobin results in decreased expression of IGFBP2 mRNA CTD PMID:33512557 benzbromarone affects expression EXP 6480464 Benzbromarone affects the expression of IGFBP2 mRNA CTD PMID:19483382 benzo[a]pyrene affects expression ISO RGD:737357 6480464 Benzo(a)pyrene affects the expression of IGFBP2 mRNA CTD PMID:20106945 benzo[a]pyrene increases methylation ISO RGD:737357 6480464 Benzo(a)pyrene results in increased methylation of IGFBP2 exon, Benzo(a)pyrene results in increased methylation of IGFBP2 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:10771 6480464 Benzo(a)pyrene results in decreased expression of IGFBP2 mRNA CTD PMID:15034205 benzo[a]pyrene multiple interactions ISO RGD:10771 6480464 AHR protein inhibits the reaction [Benzo(a)pyrene results in decreased expression of IGFBP2 mRNA] CTD PMID:15034205 benzo[a]pyrene increases expression ISO RGD:10771 6480464 Benzo(a)pyrene results in increased expression of IGFBP2 mRNA CTD PMID:20127859 more ... benzo[a]pyrene increases expression ISO RGD:737357 6480464 Benzo(a)pyrene results in increased expression of IGFBP2 mRNA CTD PMID:21632981 , PMID:22316170 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of IGFBP2 mRNA CTD PMID:21839799 benzo[a]pyrene diol epoxide I increases expression ISO RGD:737357 6480464 7 more ... CTD PMID:20382639 benzo[b]fluoranthene increases expression ISO RGD:10771 6480464 benzo(b)fluoranthene results in increased expression of IGFBP2 mRNA CTD PMID:26377693 benzo[e]pyrene increases methylation ISO RGD:737357 6480464 benzo(e)pyrene results in increased methylation of IGFBP2 intron CTD PMID:30157460 Benzo[k]fluoranthene affects expression ISO RGD:10771 6480464 benzo(k)fluoranthene affects the expression of IGFBP2 mRNA CTD PMID:26377693 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of IGFBP2 mRNA CTD PMID:18164116 bexarotene increases expression EXP 6480464 bexarotene results in increased expression of IGFBP2 mRNA CTD PMID:16648578 , PMID:17630414 bexarotene multiple interactions EXP 6480464 [Tamoxifen co-treated with bexarotene] results in increased expression of IGFBP2 mRNA CTD PMID:17630414 bicalutamide multiple interactions ISO RGD:737357 6480464 bicalutamide promotes the reaction [Dihydrotestosterone results in increased expression of IGFBP2 mRNA] CTD PMID:16368782 bicalutamide increases expression ISO RGD:737357 6480464 bicalutamide results in increased expression of IGFBP2 mRNA CTD PMID:16368782 bicalutamide increases expression EXP 6480464 bicalutamide results in increased expression of IGFBP2 mRNA CTD PMID:10604720 bisphenol A affects expression ISO RGD:10771 6480464 bisphenol A affects the expression of IGFBP2 mRNA CTD PMID:26746108 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of IGFBP2 mRNA CTD PMID:30816183 , PMID:34947998 bisphenol A decreases expression ISO RGD:737357 6480464 bisphenol A results in decreased expression of IGFBP2 mRNA CTD PMID:27685785 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of IGFBP2 mRNA CTD PMID:25181051 , PMID:30903817 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of IGFBP2 mRNA CTD PMID:32479839 bromochloroacetic acid increases expression EXP 6480464 bromochloroacetic acid results in increased expression of IGFBP2 mRNA CTD PMID:16460773 bromochloroacetic acid increases expression ISO RGD:10771 6480464 bromochloroacetic acid results in increased expression of IGFBP2 protein CTD PMID:21296659 cadmium atom multiple interactions ISO RGD:737357 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IGFBP2 mRNA CTD PMID:29741670 cadmium dichloride multiple interactions ISO RGD:737357 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IGFBP2 mRNA, Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of IGFBP2 protein] CTD PMID:26138014 , PMID:29741670 cadmium dichloride decreases expression ISO RGD:737357 6480464 Cadmium Chloride results in decreased expression of IGFBP2 protein CTD PMID:26138014 calcium atom affects expression EXP 6480464 Calcium affects the expression of IGFBP2 mRNA CTD PMID:15913539 calcium(0) affects expression EXP 6480464 Calcium affects the expression of IGFBP2 mRNA CTD PMID:15913539 carbon nanotube decreases expression ISO RGD:10771 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 carbonyl sulfide increases expression EXP 6480464 carbonyl sulfide results in increased expression of IGFBP2 mRNA CTD PMID:19395590 chlorohydrocarbon multiple interactions ISO RGD:737357 6480464 [Hydrocarbons more ... CTD PMID:31923581 chloropicrin decreases expression ISO RGD:737357 6480464 chloropicrin results in decreased expression of IGFBP2 mRNA CTD PMID:26352163 , PMID:28476498 ciprofibrate increases expression ISO RGD:10771 6480464 ciprofibrate results in increased expression of IGFBP2 mRNA CTD PMID:12771043 cisplatin increases expression ISO RGD:737357 6480464 Cisplatin results in increased expression of IGFBP2 mRNA CTD PMID:27594783 cisplatin decreases expression ISO RGD:737357 6480464 Cisplatin results in decreased expression of IGFBP2 mRNA CTD PMID:27392435 clobetasol increases expression ISO RGD:10771 6480464 Clobetasol results in increased expression of IGFBP2 mRNA CTD PMID:27462272 clofibrate affects expression EXP 6480464 Clofibrate affects the expression of IGFBP2 mRNA CTD PMID:19483382 cocaine decreases expression EXP 6480464 Cocaine results in decreased expression of IGFBP2 mRNA CTD PMID:16076954 coumestrol multiple interactions ISO RGD:737357 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IGFBP2 mRNA CTD PMID:19167446 crocidolite asbestos increases expression ISO RGD:10771 6480464 Asbestos, Crocidolite results in increased expression of IGFBP2 mRNA CTD PMID:29279043 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of IGFBP2 mRNA CTD PMID:26577399 , PMID:27523638 curcumin multiple interactions ISO RGD:737357 6480464 [arsenic trioxide co-treated with Curcumin] results in decreased expression of IGFBP2 protein CTD PMID:27430728 cyclosporin A decreases expression ISO RGD:737357 6480464 Cyclosporine results in decreased expression of IGFBP2 mRNA CTD PMID:20106945 more ... decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of IGFBP2 mRNA CTD PMID:23640034 deguelin decreases expression ISO RGD:737357 6480464 deguelin results in decreased expression of IGFBP2 mRNA CTD PMID:33512557 dexamethasone increases expression ISO RGD:737357 6480464 Dexamethasone results in increased expression of IGFBP2 mRNA CTD PMID:25047013 dexamethasone multiple interactions ISO RGD:737357 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of IGFBP2 mRNA CTD PMID:28628672 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of IGFBP2 mRNA CTD PMID:19853640 dextran sulfate multiple interactions ISO RGD:10771 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IGFBP2 mRNA CTD PMID:29950665 diarsenic trioxide decreases expression ISO RGD:737357 6480464 Arsenic Trioxide results in decreased expression of IGFBP2 mRNA CTD PMID:15070760 , PMID:15761015 diarsenic trioxide multiple interactions ISO RGD:737357 6480464 [Arsenic Trioxide co-treated with Curcumin] results in decreased expression of IGFBP2 protein, Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to IGFBP2 protein] CTD PMID:26598702 , PMID:27430728 dibenz[a,h]anthracene increases expression ISO RGD:10771 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of IGFBP2 mRNA CTD PMID:21266533 diclofenac decreases expression ISO RGD:10771 6480464 Diclofenac results in decreased expression of IGFBP2 mRNA CTD PMID:26934552 diethylstilbestrol increases expression ISO RGD:10771 6480464 Diethylstilbestrol results in increased expression of IGFBP2 mRNA CTD PMID:15171707 diethylstilbestrol increases expression ISO RGD:737357 6480464 Diethylstilbestrol results in increased expression of IGFBP2 mRNA CTD PMID:15766595 dioxygen multiple interactions EXP 6480464 Tretinoin affects the reaction [Oxygen affects the secretion of IGFBP2 protein] CTD PMID:16055936 dioxygen increases expression ISO RGD:737357 6480464 Oxygen deficiency results in increased expression of IGFBP2 mRNA CTD PMID:24236059 diuron increases expression EXP 6480464 Diuron results in increased expression of IGFBP2 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:737357 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBP2 mRNA CTD PMID:27188386 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of IGFBP2 protein CTD PMID:8792405 elemental selenium increases expression ISO RGD:737357 6480464 Selenium results in increased expression of IGFBP2 mRNA CTD PMID:19244175 ellagic acid increases expression ISO RGD:737357 6480464 Ellagic Acid results in increased expression of IGFBP2 mRNA CTD PMID:12002526 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of IGFBP2 mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO RGD:737357 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IGFBP2 mRNA CTD PMID:19167446 erythromycin estolate increases expression EXP 6480464 Erythromycin Estolate results in increased expression of IGFBP2 mRNA CTD PMID:24412560 ethanol affects expression EXP 6480464 Ethanol affects the expression of IGFBP2 mRNA CTD PMID:11772933 fenpyroximate decreases expression ISO RGD:737357 6480464 fenpyroximate results in decreased expression of IGFBP2 mRNA CTD PMID:33512557 fluoxetine decreases expression EXP 6480464 Fluoxetine results in decreased expression of IGFBP2 mRNA CTD PMID:17033635 flutamide multiple interactions ISO RGD:737357 6480464 Flutamide inhibits the reaction [Dihydrotestosterone results in increased expression of IGFBP2 mRNA] CTD PMID:16368782 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of IGFBP2 mRNA CTD PMID:24136188 furan increases expression EXP 6480464 furan results in increased expression of IGFBP2 mRNA CTD PMID:26194646 genistein increases expression ISO RGD:10771 6480464 Genistein results in increased expression of IGFBP2 mRNA CTD PMID:32186404 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of IGFBP2 mRNA CTD PMID:33387578 glycidol increases expression EXP 6480464 glycidol results in increased expression of IGFBP2 mRNA CTD PMID:24395379 griseofulvin affects expression ISO RGD:10771 6480464 Griseofulvin affects the expression of IGFBP2 mRNA CTD PMID:12735108 hexachlorobenzene multiple interactions ISO RGD:737357 6480464 [Hydrocarbons more ... CTD PMID:31923581 hydrogen peroxide increases expression ISO RGD:737357 6480464 Hydrogen Peroxide results in increased expression of IGFBP2 mRNA CTD PMID:32949572 indometacin multiple interactions ISO RGD:737357 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of IGFBP2 mRNA CTD PMID:28628672 ivermectin decreases expression ISO RGD:737357 6480464 Ivermectin results in decreased expression of IGFBP2 protein CTD PMID:32959892 L-ethionine affects expression EXP 6480464 Ethionine affects the expression of IGFBP2 mRNA CTD PMID:19483382 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of IGFBP2 mRNA CTD PMID:24136188 lipopolysaccharide decreases expression ISO RGD:10771 6480464 Lipopolysaccharides results in decreased expression of IGFBP2 mRNA CTD PMID:27339419 lycopene increases expression ISO RGD:737357 6480464 lycopene results in increased expression of IGFBP2 protein CTD PMID:17337101 menadione decreases expression ISO RGD:10771 6480464 Vitamin K 3 results in decreased expression of IGFBP2 mRNA CTD PMID:25270620 methapyrilene increases methylation ISO RGD:737357 6480464 Methapyrilene results in increased methylation of IGFBP2 intron CTD PMID:30157460 N-(6-acetamidohexyl)acetamide decreases expression ISO RGD:10771 6480464 hexamethylene bisacetamide results in decreased expression of IGFBP2 mRNA CTD PMID:26941288 N-acetyl-L-cysteine multiple interactions ISO RGD:737357 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of IGFBP2 protein] CTD PMID:26138014 N-methyl-N-nitrosourea decreases expression ISO RGD:10771 6480464 Methylnitrosourea results in decreased expression of IGFBP2 mRNA CTD PMID:25270620 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of IGFBP2 mRNA CTD PMID:18164116 N-nitrosodiethylamine increases expression ISO RGD:10771 6480464 Diethylnitrosamine results in increased expression of IGFBP2 mRNA CTD PMID:12771043 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of IGFBP2 mRNA CTD PMID:25380136 N-nitrosodimethylamine decreases expression EXP 6480464 Dimethylnitrosamine results in decreased expression of IGFBP2 mRNA CTD PMID:17072980 nickel atom decreases expression ISO RGD:737357 6480464 Nickel results in decreased expression of IGFBP2 mRNA CTD PMID:25583101 nicotine increases expression ISO RGD:737357 6480464 Nicotine results in increased expression of IGFBP2 mRNA CTD PMID:23825647 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of IGFBP2 mRNA CTD PMID:33484710 omeprazole affects expression EXP 6480464 Omeprazole affects the expression of IGFBP2 mRNA CTD PMID:19483382 ozone decreases expression EXP 6480464 Ozone results in decreased expression of IGFBP2 mRNA CTD PMID:16330353 p-menthan-3-ol increases expression ISO RGD:737357 6480464 Menthol results in increased expression of IGFBP2 mRNA CTD PMID:26760959 paracetamol affects expression ISO RGD:10771 6480464 Acetaminophen affects the expression of IGFBP2 mRNA CTD PMID:15606129 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of IGFBP2 mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:10771 6480464 Acetaminophen results in decreased expression of IGFBP2 mRNA CTD PMID:29246445 paracetamol multiple interactions ISO RGD:10771 6480464 PANX1 gene mutant form inhibits the reaction [Acetaminophen results in decreased expression of IGFBP2 mRNA] CTD PMID:29246445 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:737357 6480464 [Hydrocarbons more ... CTD PMID:31923581 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of IGFBP2 mRNA CTD PMID:19162173 , PMID:21318169 perfluorooctanoic acid multiple interactions ISO RGD:737357 6480464 [Hydrocarbons more ... CTD PMID:31923581 phenformin increases expression EXP 6480464 Phenformin results in increased expression of IGFBP2 mRNA CTD PMID:31324951 phenobarbital multiple interactions ISO RGD:10771 6480464 NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of IGFBP2 mRNA] CTD PMID:19482888 phenobarbital affects expression ISO RGD:10771 6480464 Phenobarbital affects the expression of IGFBP2 mRNA CTD PMID:23091169 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of IGFBP2 mRNA CTD PMID:19162173 phenobarbital decreases expression ISO RGD:10771 6480464 Phenobarbital results in decreased expression of IGFBP2 mRNA CTD PMID:19482888 PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of IGFBP2 mRNA CTD PMID:15215175 PhIP decreases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in decreased expression of IGFBP2 mRNA CTD PMID:15215175 picoxystrobin decreases expression ISO RGD:737357 6480464 picoxystrobin results in decreased expression of IGFBP2 mRNA CTD PMID:33512557 pirinixic acid multiple interactions ISO RGD:10771 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of IGFBP2 mRNA CTD PMID:19710929 pirinixic acid increases expression ISO RGD:10771 6480464 pirinixic acid results in increased expression of IGFBP2 mRNA CTD PMID:18301758 more ... pirinixic acid affects expression EXP 6480464 pirinixic acid affects the expression of IGFBP2 mRNA CTD PMID:19483382 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of IGFBP2 mRNA CTD PMID:19162173 , PMID:21318169 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:10771 6480464 Pregnenolone Carbonitrile results in increased expression of IGFBP2 mRNA CTD PMID:28903501 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:10771 6480464 Pregnenolone Carbonitrile results in decreased expression of IGFBP2 mRNA CTD PMID:27413110 progesterone multiple interactions ISO RGD:737357 6480464 [Estradiol co-treated with Progesterone] results in increased secretion of IGFBP2 protein CTD PMID:15809018 progesterone increases expression EXP 6480464 Progesterone results in increased expression of IGFBP2 mRNA CTD PMID:19853640 progesterone increases secretion ISO RGD:737357 6480464 Progesterone results in increased secretion of IGFBP2 protein CTD PMID:15809018 progesterone decreases expression ISO RGD:737357 6480464 Progesterone results in decreased expression of IGFBP2 mRNA CTD PMID:18070364 pyrimidifen decreases expression ISO RGD:737357 6480464 pyrimidifen results in decreased expression of IGFBP2 mRNA CTD PMID:33512557 quercetin increases expression ISO RGD:737357 6480464 Quercetin results in increased expression of IGFBP2 mRNA CTD PMID:21632981 rac-lactic acid increases expression ISO RGD:737357 6480464 Lactic Acid results in increased expression of IGFBP2 mRNA CTD PMID:30851411 resveratrol increases expression ISO RGD:737357 6480464 resveratrol results in increased expression of IGFBP2 mRNA CTD PMID:12002526 , PMID:12569576 resveratrol multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of IGFBP2 mRNA CTD PMID:25905778 riddelliine increases expression EXP 6480464 riddelliine results in increased expression of IGFBP2 mRNA CTD PMID:18047727 rotenone decreases expression ISO RGD:737357 6480464 Rotenone results in decreased expression of IGFBP2 mRNA CTD PMID:33512557 rotenone increases expression EXP 6480464 Rotenone results in increased expression of IGFBP2 mRNA CTD PMID:28374803 RU 58668 affects expression ISO RGD:737357 6480464 RU 58668 affects the expression of IGFBP2 protein CTD PMID:15868441 SB 431542 multiple interactions ISO RGD:737357 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBP2 mRNA CTD PMID:27188386 selenium atom increases expression ISO RGD:737357 6480464 Selenium results in increased expression of IGFBP2 mRNA CTD PMID:19244175 silicon dioxide increases expression ISO RGD:737357 6480464 Silicon Dioxide analog results in increased expression of IGFBP2 mRNA CTD PMID:23806026 silver atom decreases expression ISO RGD:10771 6480464 Silver results in decreased expression of IGFBP2 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:10771 6480464 Silver results in decreased expression of IGFBP2 mRNA CTD PMID:27131904 sodium arsenate decreases expression ISO RGD:737357 6480464 sodium arsenate results in decreased expression of IGFBP2 mRNA CTD PMID:12727804 sodium arsenate increases expression ISO RGD:10771 6480464 sodium arsenate results in increased expression of IGFBP2 mRNA CTD PMID:30953684 sodium arsenite decreases expression ISO RGD:10771 6480464 sodium arsenite results in decreased expression of IGFBP2 mRNA CTD PMID:17350061 , PMID:17451858 sodium arsenite affects expression ISO RGD:737357 6480464 sodium arsenite affects the expression of IGFBP2 mRNA CTD PMID:34032870 sodium arsenite decreases expression ISO RGD:737357 6480464 sodium arsenite results in decreased expression of IGFBP2 mRNA CTD PMID:12727804 sodium tungstate affects expression ISO RGD:737357 6480464 sodium tungstate(VI) affects the expression of IGFBP2 mRNA CTD PMID:26164860 streptozocin multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of IGFBP2 mRNA CTD PMID:25905778 sunitinib decreases expression ISO RGD:737357 6480464 Sunitinib results in decreased expression of IGFBP2 mRNA CTD PMID:31533062 tamibarotene affects expression ISO RGD:737357 6480464 tamibarotene affects the expression of IGFBP2 mRNA CTD PMID:15498508 tamoxifen increases expression ISO RGD:10771 6480464 Tamoxifen results in increased expression of IGFBP2 mRNA CTD PMID:17555576 tamoxifen multiple interactions EXP 6480464 [Tamoxifen co-treated with bexarotene] results in increased expression of IGFBP2 mRNA CTD PMID:17630414 tamoxifen decreases expression EXP 6480464 Tamoxifen results in decreased expression of IGFBP2 mRNA CTD PMID:17630414 tebufenpyrad decreases expression ISO RGD:737357 6480464 4-chloro-N-((4-(1, 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of IGFBP2 mRNA CTD PMID:33512557 temozolomide increases expression ISO RGD:737357 6480464 Temozolomide results in increased expression of IGFBP2 mRNA CTD PMID:31758290 tert-butyl hydroperoxide decreases expression ISO RGD:737357 6480464 tert-Butylhydroperoxide results in decreased expression of IGFBP2 mRNA CTD PMID:15336504 testosterone increases expression ISO RGD:737357 6480464 Testosterone results in increased expression of IGFBP2 mRNA, Testosterone results in increased expression of IGFBP2 protein CTD PMID:15817916 , PMID:16368782 tetrachloromethane decreases expression ISO RGD:10771 6480464 Carbon Tetrachloride results in decreased expression of IGFBP2 mRNA CTD PMID:27339419 , PMID:31919559 tetracycline decreases expression ISO RGD:10771 6480464 Tetracycline results in decreased expression of IGFBP2 mRNA CTD PMID:24489787 thapsigargin decreases expression ISO RGD:737357 6480464 Thapsigargin results in decreased expression of IGFBP2 mRNA CTD PMID:22378314 thimerosal decreases expression ISO RGD:737357 6480464 Thimerosal results in decreased expression of IGFBP2 mRNA CTD PMID:27188386 thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of IGFBP2 mRNA CTD PMID:19483382 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of IGFBP2 mRNA CTD PMID:34492290 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of IGFBP2 mRNA CTD PMID:23411599 titanium dioxide increases expression ISO RGD:10771 6480464 titanium dioxide results in increased expression of IGFBP2 mRNA, titanium dioxide results in increased expression of IGFBP2 protein CTD PMID:23409001 , PMID:23565150 titanium dioxide multiple interactions ISO RGD:10771 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IGFBP2 mRNA CTD PMID:29950665 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of IGFBP2 mRNA CTD PMID:30012374 triclosan increases expression ISO RGD:737357 6480464 Triclosan results in increased expression of IGFBP2 mRNA CTD PMID:30510588 trimellitic anhydride increases expression ISO RGD:10771 6480464 trimellitic anhydride results in increased expression of IGFBP2 mRNA CTD PMID:19042947 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of IGFBP2 mRNA CTD PMID:30589522 troglitazone decreases expression ISO RGD:737357 6480464 troglitazone results in decreased expression of IGFBP2 mRNA CTD PMID:25572481 tunicamycin decreases expression ISO RGD:737357 6480464 Tunicamycin results in decreased expression of IGFBP2 mRNA CTD PMID:22378314 valproic acid affects expression ISO RGD:10771 6480464 Valproic Acid affects the expression of IGFBP2 mRNA CTD PMID:17292431 , PMID:17963808 valproic acid multiple interactions ISO RGD:737357 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBP2 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:737357 6480464 Valproic Acid results in increased expression of IGFBP2 mRNA CTD PMID:19101580 more ... valproic acid affects expression ISO RGD:737357 6480464 Valproic Acid affects the expression of IGFBP2 mRNA CTD PMID:25979313 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of IGFBP2 mRNA CTD PMID:21318169 vemurafenib multiple interactions ISO RGD:737357 6480464 [(+)-JQ1 compound co-treated with vemurafenib] results in increased expression of IGFBP2 protein CTD PMID:27169980 vitamin E increases expression ISO RGD:737357 6480464 Vitamin E results in increased expression of IGFBP2 mRNA CTD PMID:19244175 vorinostat increases expression ISO RGD:10771 6480464 vorinostat results in increased expression of IGFBP2 mRNA CTD PMID:26941288 zinc atom decreases expression EXP 6480464 Zinc deficiency results in decreased expression of IGFBP2 mRNA CTD PMID:12672911 zinc oxide affects expression EXP 6480464 Zinc Oxide affects the expression of IGFBP2 protein CTD PMID:33205376 zinc(0) decreases expression EXP 6480464 Zinc deficiency results in decreased expression of IGFBP2 mRNA CTD PMID:12672911